Two separate groups found that glutamine deprivation in cell lines of human clear cell renal carcinoma[182], human non-small cell lung carcinoma[183], and mouse colorectal carcinoma[183] induced PD-L1 expression, which would theoretically boost anti-PD-L1 response. The gene discussed is CD274; the disease is clear cell renal carcinoma.